Phillip P. Chan

Insider Reports History

Reporting-owner location: Mount Laurel, NJ
Latest reporting-owner signature: /s/ Phillip P. Chan
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Phillip P. Chan

Form 4 holding Chief Executive Officer, Director

Cytosorbents Corp

Security class: Common Stock
Shares / value: 1,744,432
Estimated value: $750,105
Report date: 15 Jun 2026
Price: $0.4300
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Cytosorbents Corp

Security class: Series A Right Warrants (right to buy)
Shares / value: 0
Estimated value: $0
Report date: 24 Feb 2025
Price: $1.13
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Cytosorbents Corp

Security class: Stock Option (Right to Buy)
Shares / value: 136,400
Estimated value
Report date: 08 Aug 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Cytosorbents Corp

Security class: Series A Right Warrants
Shares / value: 90,832
Estimated value
Report date: 17 Jan 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Cytosorbents Corp

Security class: Series B Right Warrants
Shares / value: 90,832
Estimated value
Report date: 17 Jan 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Cytosorbents Corp

Security class: Subscription Rights (right to buy)
Shares / value: 0
Estimated value
Report date: 17 Jan 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Phillip P. Chan

4 CTSO

Cytosorbents Corp

Report period: 12 Jun 2026
Transactions: 2
Transaction value: +$104,898
Accepted by SEC: 15 Jun 2026, 18:24
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 18 Nov 2025
Transactions: 1
Transaction value: +$64,000
Accepted by SEC: 20 Nov 2025, 21:09
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 08 Aug 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 08 Aug 2025, 19:40
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 24 Feb 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 26 Feb 2025, 19:27
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 17 Jan 2025
Transactions: 4
Transaction value: +$90,832
Accepted by SEC: 22 Jan 2025, 20:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 02 Apr 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Apr 2024, 21:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 29 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Apr 2024, 21:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 13 Dec 2023
Transactions: 2
Transaction value: +$100,000
Accepted by SEC: 15 Dec 2023, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 07 Jul 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 11 Jul 2023, 20:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 03 Apr 2023
Transactions: 2
Transaction value: +$87,688
Accepted by SEC: 05 Apr 2023, 17:00
Role: Chief Executive Officer
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 08 Dec 2022
Transactions: 1
Transaction value: +$7,382
Accepted by SEC: 09 Dec 2022, 15:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 06 Dec 2022
Transactions: 2
Transaction value: +$30,475
Accepted by SEC: 08 Dec 2022, 15:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 08 Sep 2022
Transactions: 1
Transaction value: +$59,500
Accepted by SEC: 12 Sep 2022, 08:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 10 Aug 2022
Transactions: 3
Transaction value: $0
Accepted by SEC: 12 Aug 2022, 18:46
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 16 Jun 2022
Transactions: 1
Transaction value: +$4,109
Accepted by SEC: 21 Jun 2022, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 09 Jun 2022
Transactions: 1
Transaction value: +$34,784
Accepted by SEC: 10 Jun 2022, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 29 Dec 2021
Transactions: 3
Transaction value: +$60,749
Accepted by SEC: 03 Jan 2022, 19:00
Role: Chief Executive Officer
Next action: Open filing details

4 CTSO

Cytosorbents Corp

Report period: 10 Dec 2021
Transactions: 1
Transaction value: +$26,250
Accepted by SEC: 13 Dec 2021, 08:05
Role: Chief Executive Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .